Two new studies, one based on households in southeast Michigan and one involving hospitalized Japanese adults, compare ...

Of all the things you can get sick with this winter, respiratory syncytial virus (RSV) should be top of mind. With positivity ...

Fact checked by Nick Blackmer Despite a temporary freeze on public communications, the Centers for Disease Control and ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

RSV is a common virus that affects the lungs and breathing passages, and here are some steps you can take to protect yourself ...

Hospital visits in Illinois due to flu are "quite high," with COVID and RSV also circulating. But what are the symptoms of ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t afford to pay $350 for a one-off vaccine.

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...